GO
Loading...

Squawk Box

More

  • Growing market bullishness not a concern yet Monday, 9 Jun 2014 | 3:58 PM ET
    Traders on the floor of the New York Stock Exchange.

    Stocks set records despite light volumes, low volatility and low rates. Major averages lift off on modest economic growth.

  • I love this 'damnable' bank stock: Fund manager Tuesday, 10 Jun 2014 | 9:09 AM ET

    This bank's "sins" are 6 to 8 years old and the good things are all coming, value investor Bill Smead tells CNBC.

  • Energy sector near record highs     Monday, 9 Jun 2014 | 8:23 AM ET

    CNBC's Dominic Chu reports the 2 best performing sectors in the S&P 500 this year have been utilities and health care. A quick look at #3, which is energy up 8 percent this year.

  • World Cup chaos     Monday, 9 Jun 2014 | 8:16 AM ET

    CNBC's Michelle Caruso-Cabrera reports on the scandal dominating headlines in the soccer community right now ahead of the World Cup in Brazil.

  • Rags to riches reveal secrets     Monday, 9 Jun 2014 | 8:57 AM ET

    CNBC's Robert Frank provides a preview of CNBC's next season of "Secret Lives of the Super Rich," including the story of billionaire developer Steve Morgan who still works 80 hours a week.

  • Pimco's stock picks     Monday, 9 Jun 2014 | 8:12 AM ET

    Pimco's deputy CIO Mark Kiesel, shares some of his firm's top stock picks, including Targa Resources and USG Corp.

  • Why BofA has a bright future: Fund manager     Tuesday, 10 Jun 2014 | 6:42 AM ET

    Bill Smead, head of his namesake investment firm, tells CNBC that shares of Bank of America could nearly double in five years.

  • Pimco's deputy CIO Mark Kiesel, discusses his firm's outlook for stocks and bonds right now.

  • Cramer's stocks to watch: Merck buys Idenix     Monday, 9 Jun 2014 | 8:51 AM ET

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.

  • Ackman: Could absolutely team up with Icahn     Monday, 9 Jun 2014 | 8:06 AM ET

    Bill Ackman, founder and CEO of Pershing Square Capital Management, says he wants to help Carl Icahn "find a way out of Herbalife," and why they are friendly again.

  • Big implications of new technologies     Tuesday, 10 Jun 2014 | 6:38 AM ET

    Rob Nail, Singularity University CEO, discusses the impact of exponential technologies on finance. Nail says every industry is being impacted by technologies powered by information layers.

  • Discussing who is vulnerable amid multiple investigations into Herbalife, the company's aggressive buyback, with Bill Ackman, founder and CEO of Pershing Square Capital Management.

  • B&G Foods CEO open to right offer     Monday, 9 Jun 2014 | 8:44 AM ET

    Discussing Tyson's win to buy Hillshire Brands, and M&A in the food industry, with B&G Foods CEO David Wenner.

  • Ackman explains Valeant bid     Monday, 9 Jun 2014 | 7:52 AM ET

    Bill Ackman, founder and CEO of Pershing Square Capital Management, answers why he thinks Valeant's potential takeover of Allergan is beneficial, and the 'unprecedented' terms in the bid.

  • B&G Foods CEO says business 'stable'     Monday, 9 Jun 2014 | 8:42 AM ET

    Discussing "very little" food price pressure for his business, and how the acquisition of brands happens in the food industry, with B&G Foods CEO David Wenner.

  • Dive into jobs picture     Monday, 9 Jun 2014 | 8:31 AM ET

    CNBC's Steve Liesman provides insight to controversy about jobs data.

  • Sen. Portman: American businesses shrinking     Monday, 9 Jun 2014 | 7:37 AM ET

    Ohio Sen. Rob Portman (R), provides perspective on lower tax rates around the world compared to the U.S., saying the international taxation system needs to be changed.

  • Merck acquires Idenix     Monday, 9 Jun 2014 | 7:31 AM ET

    Merck announced it will buy biotechnology company Idenix for $24.50 per share in cash, with the "Squawk Box" crew.

  • Pharma industry 'Shakespearean drama'     Monday, 9 Jun 2014 | 7:19 AM ET

    Discussing the evolution of big pharmaceutical companies, and Valeant's old and new R&D model, with Michael Porter, Harvard Business School professor. Bill Ackman, founder and CEO of Pershing Square Capital Management, weighs in.

  • Ackman says Chanos wrong on Valeant     Monday, 9 Jun 2014 | 7:09 AM ET

    Bill Ackman, founder and CEO of Pershing Square Capital Management, discusses James Chanos' short thesis of Valeant Pharmaceuticals.

About Squawk Box

  • "Squawk Box" is the ultimate "pre-market" morning news and talk program, where the biggest names in business and politics tell their most important stories. Anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin, the show brings Wall Street to Main Street. It's a "must see" for everyone from the professional trader to the casual investor.

Contact Squawk Box

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More
  • Showtimes

    U.S.
    Weekdays 6a ET
    EMEA
    Weekdays 13:00 CET
    Asia
    Weekdays 18:00 SIN/HK
    Australia
    Weekdays 20:00 SYD
    New Zealand
    Weekdays 22:00 NZ

 

  • Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.

  • "Squawk Box" Co-Anchor

  • Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.